MedPath

Evaluation of Orientation and Visual Acuity of Four Toric Soft Contact Lenses When Head is Tilted at 90 Degrees

Not Applicable
Completed
Conditions
Astigmatism
Interventions
Device: senofilcon A
Device: balafilcon A toric
Device: lotrafilcon B toric
Device: omafilcon A
Registration Number
NCT00583908
Lead Sponsor
Johnson & Johnson Vision Care, Inc.
Brief Summary

The purpose of this study is to determine the relative performance of a new toric soft contact lens against three toric contact lens currently available in market, specifically with orientation and visual acuity when head is tilted at 90 degrees.

Detailed Description

Non-dispensing single-masked (subject-masked), randomised, 1-visit controlled study, \~2 hour duration.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  1. be at least 18 and less than or equal to 50 years of age
  2. be able and willing to adhere to the instructions set forth in the protocol.
  3. have a distance spherical component between -1.00 D and -6.00D with cylinder in the range of 0.75 D to 1.75D
  4. Sign the STATEMENT OF INFORMED CONSENT.
  5. Have normal, healthy eyes
Exclusion Criteria
  1. The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear.
  2. Pre-existing ocular disease precluding contact lens fitting.
  3. Insufficient lacrimal secretions
  4. Aphakia, keratoconus or a highly irregular cornea
  5. Previous eye surgery involving the anterior segment
  6. Current pregnancy or lactation (to the best of the subject's knowledge).
  7. Use of concurrent ocular medication
  8. Active participation in another clinical study at any time during this study.-

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Group 7 omafilcon B/lotrafilcon B/senofilcon A/balafilcon Asenofilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: omafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: balafilcon A
Group 8 balafilcon A/lotrafilcon B/senofilcon A/omafilcon Abalafilcon A toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: omafilcon A
Group 2 lotrafilcon B/omafilcon A/senofilcon A/balafilcon Abalafilcon A toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: omafilcon A / period 3: senofilcon A / period 4: balafilcon A
Group 5 senofilcon A/omafilcon A/balafilcon A/lotrafilcon Bsenofilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: omafilcon A / period 3: balafilcon A / period 4: lotrafilcon B
Group 5 senofilcon A/omafilcon A/balafilcon A/lotrafilcon Blotrafilcon B toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: omafilcon A / period 3: balafilcon A / period 4: lotrafilcon B
Group 6 senofilcon A/balafilcon A/lotrafilcon B/omafilcon Alotrafilcon B toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: balafilcon A / period 3: lotrafilcon B / period 4: omafilcon A
Group 2 lotrafilcon B/omafilcon A/senofilcon A/balafilcon Asenofilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: omafilcon A / period 3: senofilcon A / period 4: balafilcon A
Group 3 lotrafilcon B/balafilcon A/senofilcon A/omafilcon Asenofilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: balafilcon A / period 3: senofilcon A / period 4: omafilcon A
Group 3 lotrafilcon B/balafilcon A/senofilcon A/omafilcon Abalafilcon A toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: balafilcon A / period 3: senofilcon A / period 4: omafilcon A
Group 3 lotrafilcon B/balafilcon A/senofilcon A/omafilcon Alotrafilcon B toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: balafilcon A / period 3: senofilcon A / period 4: omafilcon A
Group 4 senofilcon A/lotrafilcon B/omafilcon A/balafilcon Abalafilcon A toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: balafilcon A
Group 1: lotrafilcon B/senofilcon A/balafilcon A/omafilcon Asenofilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. Period 1: lotrafilcon B /period 2: senofilcon A / period 3: balafilcon A / period 4: omafilcon A
Group 1: lotrafilcon B/senofilcon A/balafilcon A/omafilcon Abalafilcon A toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. Period 1: lotrafilcon B /period 2: senofilcon A / period 3: balafilcon A / period 4: omafilcon A
Group 2 lotrafilcon B/omafilcon A/senofilcon A/balafilcon Alotrafilcon B toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: omafilcon A / period 3: senofilcon A / period 4: balafilcon A
Group 2 lotrafilcon B/omafilcon A/senofilcon A/balafilcon Aomafilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: omafilcon A / period 3: senofilcon A / period 4: balafilcon A
Group 3 lotrafilcon B/balafilcon A/senofilcon A/omafilcon Aomafilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: balafilcon A / period 3: senofilcon A / period 4: omafilcon A
Group 4 senofilcon A/lotrafilcon B/omafilcon A/balafilcon Aomafilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: balafilcon A
Group 5 senofilcon A/omafilcon A/balafilcon A/lotrafilcon Bbalafilcon A toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: omafilcon A / period 3: balafilcon A / period 4: lotrafilcon B
Group 5 senofilcon A/omafilcon A/balafilcon A/lotrafilcon Bomafilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: omafilcon A / period 3: balafilcon A / period 4: lotrafilcon B
Group 1: lotrafilcon B/senofilcon A/balafilcon A/omafilcon Alotrafilcon B toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. Period 1: lotrafilcon B /period 2: senofilcon A / period 3: balafilcon A / period 4: omafilcon A
Group 1: lotrafilcon B/senofilcon A/balafilcon A/omafilcon Aomafilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. Period 1: lotrafilcon B /period 2: senofilcon A / period 3: balafilcon A / period 4: omafilcon A
Group 4 senofilcon A/lotrafilcon B/omafilcon A/balafilcon Asenofilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: balafilcon A
Group 4 senofilcon A/lotrafilcon B/omafilcon A/balafilcon Alotrafilcon B toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: balafilcon A
Group 7 omafilcon B/lotrafilcon B/senofilcon A/balafilcon Abalafilcon A toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: omafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: balafilcon A
Group 7 omafilcon B/lotrafilcon B/senofilcon A/balafilcon Aomafilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: omafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: balafilcon A
Group 8 balafilcon A/lotrafilcon B/senofilcon A/omafilcon Asenofilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: omafilcon A
Group 6 senofilcon A/balafilcon A/lotrafilcon B/omafilcon Abalafilcon A toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: balafilcon A / period 3: lotrafilcon B / period 4: omafilcon A
Group 7 omafilcon B/lotrafilcon B/senofilcon A/balafilcon Alotrafilcon B toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: omafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: balafilcon A
Group 11 balafilcon A/senofilcon A/omafilcon A//lotrafilcon Bbalafilcon A toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: omafilcon A / period 4: lotrafilcon B
Group 12 balafilcon A/omafilcon A/lotrafilcon B/senofilcon Asenofilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: omafilcon A / period 3: lotrafilcon B / period 4: senofilcon A
Group 12 balafilcon A/omafilcon A/lotrafilcon B/senofilcon Alotrafilcon B toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: omafilcon A / period 3: lotrafilcon B / period 4: senofilcon A
Group 6 senofilcon A/balafilcon A/lotrafilcon B/omafilcon Asenofilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: balafilcon A / period 3: lotrafilcon B / period 4: omafilcon A
Group 6 senofilcon A/balafilcon A/lotrafilcon B/omafilcon Aomafilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: balafilcon A / period 3: lotrafilcon B / period 4: omafilcon A
Group 8 balafilcon A/lotrafilcon B/senofilcon A/omafilcon Alotrafilcon B toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: omafilcon A
Group 9 balafilcon A/lotrafilcon B/omafilcon A/senofilcon Abalafilcon A toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: senofilcon A
Group 9 balafilcon A/lotrafilcon B/omafilcon A/senofilcon Alotrafilcon B toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: senofilcon A
Group 10 balafilcon A/senofilcon A/lotrafilcon B/omafilcon Aomafilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: lotrafilcon B / period 4: omafilcon A
Group 11 balafilcon A/senofilcon A/omafilcon A//lotrafilcon Blotrafilcon B toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: omafilcon A / period 4: lotrafilcon B
Group 12 balafilcon A/omafilcon A/lotrafilcon B/senofilcon Abalafilcon A toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: omafilcon A / period 3: lotrafilcon B / period 4: senofilcon A
Group 8 balafilcon A/lotrafilcon B/senofilcon A/omafilcon Aomafilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: omafilcon A
Group 9 balafilcon A/lotrafilcon B/omafilcon A/senofilcon Asenofilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: senofilcon A
Group 10 balafilcon A/senofilcon A/lotrafilcon B/omafilcon Asenofilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: lotrafilcon B / period 4: omafilcon A
Group 11 balafilcon A/senofilcon A/omafilcon A//lotrafilcon Bsenofilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: omafilcon A / period 4: lotrafilcon B
Group 10 balafilcon A/senofilcon A/lotrafilcon B/omafilcon Abalafilcon A toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: lotrafilcon B / period 4: omafilcon A
Group 9 balafilcon A/lotrafilcon B/omafilcon A/senofilcon Aomafilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: senofilcon A
Group 10 balafilcon A/senofilcon A/lotrafilcon B/omafilcon Alotrafilcon B toricOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: lotrafilcon B / period 4: omafilcon A
Group 11 balafilcon A/senofilcon A/omafilcon A//lotrafilcon Bomafilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: omafilcon A / period 4: lotrafilcon B
Group 12 balafilcon A/omafilcon A/lotrafilcon B/senofilcon Aomafilcon AOne intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: omafilcon A / period 3: lotrafilcon B / period 4: senofilcon A
Primary Outcome Measures
NameTimeMethod
Visual Acuity During Head Tiltafter each of the four lens insertions

logarithm of the minimum angle of resolution (logMar) ideal is 0.0 and represents 20/20 Snellen acuity.

logMar values \> 0.00 indicate vision poorer than the ideal and values \<0.00 indicate vision greater than the ideal.

Lens Orientation During Head Tilt.after fit of each of the four lens insertions

Degree of lens rotation on the eye with the head tilted.

Secondary Outcome Measures
NameTimeMethod
Degree of Lens Rotation in Temporal Gaze.After each of the four lens insertions

Degree of lens rotation while participant is gazing out(towards the temple).

Degree of Lens Rotation in Superior Gaze.After each of the four lens insertions

Degree of lens rotation while participant is gazing up.

Degree of Lens Rotation in Superior-temporal Gaze.After each of 4 lens insertions.,

Degree of lens rotation while participant is gazing up and out(towards the temple).

Degree of Lens Rotation in Inferior Gaze.After each of the four lens insertions

Degree of lens rotation while participant is gazing down.

Degree of Lens Rotation Inferior-temporal Gaze.After each of the four lens insertions

Degree of lens rotation while participant is gazing down and out.

Degree of Lens Rotation in Superior-nasal Gaze.After each of the four lens insertions

Degree of lens rotation while participant is gazing up and in(towards the nose).

Degree of Lens Rotation in Nasal Gaze.After each of the four lens insertions

Degree of lens rotation while participant is gazing in(towards the nose).

Degree of Lens Rotation in Inferior-nasal Gaze.After each of the four lens insertions

Degree of lens rotation while participant is gazing down and in.

Trial Locations

Locations (1)

Visioncare Research Ltd.

🇬🇧

Farnham, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath